Related Experiment Video
Updated: Jan 5, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
A Test for More Accurate Diagnosis of Pulmonary Tuberculosis
Lin Sun1,2, Xue Qi1,2, Fang Liu2,3
1Bejing Key Laboratory of Pediatric Respiratory Infectious Diseases, Beijing Pediatric Research Institute, Beijing, China.
Insights
The Xpert MTB/RIF Ultra assay shows good sensitivity and specificity for diagnosing childhood tuberculosis using bronchoalveolar lavage fluid. This molecular test aids in rapid and accurate pediatric tuberculosis detection when sputum is unavailable.
Area of Science:
- Pediatric infectious diseases
- Molecular diagnostics
- Mycobacterial infections
Background:
- The Xpert MTB/RIF Ultra assay is widely used for adult tuberculosis diagnosis.
- Diagnostic accuracy data for childhood tuberculosis using this assay are limited.
- Obtaining quality sputum samples from children is challenging.
Purpose of the Study:
- To evaluate the diagnostic accuracy and clinical utility of the Xpert MTB/RIF Ultra assay for childhood tuberculosis.
- To assess the assay's performance using bronchoalveolar lavage fluid in pediatric patients.
Main Methods:
- The study enrolled 93 children with pulmonary tuberculosis and 128 with respiratory infections.
- Diagnostic accuracy was determined against bacteriologic results and clinical evidence.
- Concordance with the standard Xpert MTB/RIF assay was assessed using kappa coefficients.
Main Results:
- The Xpert MTB/RIF Ultra assay demonstrated a sensitivity of 70% for all pulmonary tuberculosis cases and 91% for bacteriologically confirmed cases.
- Specificity was high at 98%, with good agreement (kappa = 0.84) compared to the Xpert MTB/RIF assay.
- The assay detected Mycobacterium tuberculosis in 58% of cases with negative culture or acid-fast staining.
Conclusions:
- The Xpert MTB/RIF Ultra assay using bronchoalveolar lavage fluid offers good sensitivity for diagnosing pediatric pulmonary tuberculosis.
- The assay provides significant clinical value for rapid and accurate diagnosis in children.
- It is a valuable tool when sputum collection is difficult.
Objectives:
Xpert Mycobacterium tuberculosis and rifampicin (MTB/RIF) Ultra assay has increasingly been used in adult tuberculosis diagnosis, but data relating to its diagnostic accuracy in children are lacking. Because a qualified sputum specimen is difficult to obtain in children, this study evaluated the diagnostic value of Ultra in childhood tuberculosis using bronchoalveolar lavage fluid.
Methods:
The accuracy of Ultra was calculated by using bacteriologic results and clinical evidence as reference standards. Concordance between Ultra and Xpert MTB/RIF assays was assessed by using к coefficients.
Results:
In total, 93 children with pulmonary tuberculosis and 128 children with respiratory tract infections were enrolled. The sensitivity of Ultra, in all pulmonary tuberculosis cases and in bacteriologically confirmed tuberculosis cases, was 70% and 91%, respectively. Ultra could detect Mycobacterium tuberculosis in 58% of cases with negative culture or acid-fast-staining results. The specificity of Ultra was 98%. There was no significant difference in sensitivity between samples with a volume ≤1 and >1 mL (66% vs 73%; P = .50; odds ratio [OR] = 0.71). Among 164 children for which Ultra and Xpert were simultaneously performed, the sensitivity was 80% and 67%, respectively, indicating good agreement (к = 0.84). An additional 6 children were identified as Ultra-positive but Xpert-negative. The positive rate decreased from 93% to 63% after 1 month (P = .01; OR = 0.12) and to 71% after 2 months (P = .03; OR = 0.18) of antituberculosis treatment.
Conclusions:
Ultra using bronchoalveolar lavage fluid has good sensitivity compared with bacteriologic tests and adds clinical value by assisting the rapid and accurate diagnosis of pulmonary tuberculosis in children.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment

